Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...

The pharmaceutical industry is undergoing ... and address any challenges that may arise during the manufacturing process. Effective project management and open communication are critical for ...

The biotechnology product manufacturing market is projected to reach USD 2397.0 billion by 2032, exhibiting a CAGR of 10.56% NEW YORK , NY, UNITED STATES, January 13, 2025 /EINPresswire / -- WGR ...

On February 7, 2024, the Delhi High Court, led by Justices Yashwant Varma and Dharmesh Sharma, delivered a 188-page landmark ...

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...

Windlas Biotech added 1.76% to Rs 1,033.15 after the company announced that its new state-of-the-art injectable facility has received Good Manufacturing Practices (GMP) certification. The ...

Continued pricing pressures from governments and patient groups are driving small molecule CDMOs to focus on reducing the ...

Biotechnology Product Manufacturing Market The biotechnology product manufacturing market is projected to reach USD 2397.0 billion by 2032, exhibiting a CAGR of 10.56% NEW YORK , NY, UNITED STATES, Ja ...

Potential applications are numerous, including pharmaceutical ... Nov. 9, 2023 — Scientists used their expertise in quantum biology, artificial intelligence and bioengineering to improve how ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...